Cleaning Validation Regulations for Biopharmaceuticals: Strategies for Compliance

Instructor: Paula Shadle
Product ID: 700088
Training Level: Intermediate
  • Duration: 60 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

In this Cleaning Validation training will discuss strategies that assure that cleaning validation is started at the optimal time of the product development cycle, current trends, and some of the challenges that must be addressed.

Cleaning validation is required prior to product licensure. Biopharmaceuticals may require different sorts of assays, and defining an acceptable residue limit can be a challenge.Early in development, cleaning monitoring is required. This talk will discuss strategies that assure that cleaning validation is started at the optimal time of the product development cycle, current trends, and some of the challenges that must be addressed.

Areas Covered in the seminar:

  • Biopharmaceuticals vs. drugs—differences
  • Cleaning assessment and monitoring—early development
  • Strategies for efficient cleaning validation
  • Microbiological concerns
  • Investigations, exceptions, and cycle re-development
  • Considerations when using a CMO (contract manufacturer)
  • Recent regulatory findings related to cleaning and validation
  • Risk assessment, new ICH draft guidelines, and other regulatory trends

Who Will Benefit:

  • Development scientists
  • QC and analytical methods development scientists and managers
  • QA managers and personnel
  • Manufacturing
  • Validation engineers

Instructor Profile:

Paula Shadle, Ph.D., has over 20 years of hands-on and executive experience in biopharmaceutical and pharmaceutical process development and quality, 35 publications and 4 process patents. Dr. Shadle has written over 35 technical publications and was co-inventor on four process patents, and teaches adult education for the University of Wisconsin, the Parenteral Drug Association, PQRI and the Institute for International Research. In 2000, Dr. Shadle received the Judith Pool Award for excellence in teaching and mentoring from AWIS. She was on the planning committee for the 2001-2003 PDA-FDA Meetings, and is Member-At-Large in the West Coast Chapter of PDA. She has spoken at several EBC briefings, and is a member of the Parenteral Drug Association, the American Society for Quality, the Association for Women in Science, and the California Separations Society (CaSSS). Dr. Shadle is on the editorial board of the journal BioPharm International, and often writes about quality and science. She is currently Member-At-Large in the West Coast Chapter of PDA, Treasurer of the East Bay Chapter of AWIS (Associate for Women in Science), an organization that mentors and supports women in the sciences.

Dr. Shadle received her B.S. and Ph.D. in biochemistry at the University of California and postdoctoral training at the Max-Planck Institute in Germany. She worked in technical and quality control/assurance positions of increasing responsibility at Chiron Corporation, Scios Inc., GlaxoSmithKline plc, and Bayer Corporation before founding Shadle Consulting. At GSK she was director of downstream process development, then of biopharmaceutical quality operations, overseeing QA, QC, analytical methods and validation. At Bayer Corporation, Dr. Shadle was director of quality control of marketed products.

Dr Shadle founded Shadle Consulting in 2001, which offers consulting services for biotechnology and biopharmaceutical firms in quality, process development, and strategic planning of quality systems. Services provided include internal and external audits, GMP training, QC laboratories, and QA systems. Experienced with clinical trials materials, process validation, and more.

Related Documents :
Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews Write review

Best Sellers
You Recently Viewed